[89Zr]Zr-DFO-NY003

N/A

Report date: 2025/10/29 10:33:36

Base Information

Drug Name[89Zr]Zr-DFO-NY003

Drug Alias NameN/A

ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Radionuclide Drug Conjugates +[5]

Mechanisms of ActionAnti-Trop-2

TargetsTumor-associated calcium signal transducer 2

Therapy Area/IndicationsTriple Negative Breast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesChinese Academy Of Medical Sciences

China Registration ClassN/A

Develop Information

Active CompaniesChinese Academy Of Medical Sciences

Inactive CompaniesN/A

Active IndicationsTriple Negative Breast Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A